WO2010086482A1 - Procédé chimio-enzymatique pour la synthèse de 1-déoxy-d-xylulose - Google Patents
Procédé chimio-enzymatique pour la synthèse de 1-déoxy-d-xylulose Download PDFInfo
- Publication number
- WO2010086482A1 WO2010086482A1 PCT/ES2010/070043 ES2010070043W WO2010086482A1 WO 2010086482 A1 WO2010086482 A1 WO 2010086482A1 ES 2010070043 W ES2010070043 W ES 2010070043W WO 2010086482 A1 WO2010086482 A1 WO 2010086482A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- xylulose
- deoxy
- fsa
- synthesis
- enzyme
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 25
- IGUZJYCAXLYZEE-RFZPGFLSSA-N 1-deoxy-D-xylulose Chemical compound CC(=O)[C@@H](O)[C@H](O)CO IGUZJYCAXLYZEE-RFZPGFLSSA-N 0.000 title claims abstract description 18
- 230000015572 biosynthetic process Effects 0.000 title description 16
- 238000003786 synthesis reaction Methods 0.000 title description 15
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 claims abstract description 16
- NFNOAHXEQXMCGT-UHFFFAOYSA-N 2-phenylmethoxyacetaldehyde Chemical compound O=CCOCC1=CC=CC=C1 NFNOAHXEQXMCGT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000006668 aldol addition reaction Methods 0.000 claims abstract description 8
- 238000007327 hydrogenolysis reaction Methods 0.000 claims abstract description 6
- 230000003197 catalytic effect Effects 0.000 claims abstract description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 4
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 239000003054 catalyst Substances 0.000 claims description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 9
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 7
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 7
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 claims description 6
- GSXOAOHZAIYLCY-HSUXUTPPSA-N keto-D-fructose 6-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-HSUXUTPPSA-N 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229910052763 palladium Inorganic materials 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 229910052707 ruthenium Inorganic materials 0.000 claims description 2
- RWZATQKQMVVYJV-VXGBXAGGSA-N (3s,4r)-3,4-dihydroxy-5-phenylmethoxypentan-2-one Chemical compound CC(=O)[C@@H](O)[C@H](O)COCC1=CC=CC=C1 RWZATQKQMVVYJV-VXGBXAGGSA-N 0.000 abstract description 7
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- GNGACRATGGDKBX-UHFFFAOYSA-N Dihydroxyacetone phosphate Natural products OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 8
- WGCNASOHLSPBMP-UHFFFAOYSA-N Glycolaldehyde Chemical compound OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N 1,3,4,5-tetrahydroxypentan-2-one Chemical compound OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- AJPADPZSRRUGHI-RFZPGFLSSA-N 1-deoxy-D-xylulose 5-phosphate Chemical compound CC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O AJPADPZSRRUGHI-RFZPGFLSSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 102000003677 Aldehyde-Lyases Human genes 0.000 description 1
- 108090000072 Aldehyde-Lyases Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005575 aldol reaction Methods 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- -1 benzyloxyacetaldehyde aldehyde Chemical class 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 238000013452 biotechnological production Methods 0.000 description 1
- 125000005340 bisphosphate group Chemical group 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 150000001749 carotenones Chemical class 0.000 description 1
- 235000005472 carotenones Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000003863 metallic catalyst Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 1
- 239000011678 thiamine pyrophosphate Substances 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/08—Deoxysugars; Unsaturated sugars; Osones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/17—Saturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the present invention relates to a chemo-enzymatic process for the synthesis of 1-deoxy-D-xylulose. Therefore, the invention falls within the chemical and biotechnological sector.
- the 1-deoxy-D-xylulose is a pentulose of great importance because it is easily incorporated into the metabolic pathway of the mevalonate (independent of methylerythriol phosphate) for the biosynthesis of isoprenoids, which take place in bacteria and plants.
- the interest in the biosynthesis of thiamine diphosphate, pyridoxal phosphate and isoprenoids has aroused many expectations in 1-deoxy-D-xylulose for biotechnological uses.
- 1-deoxy-D-xylulose is particularly valuable in the biotechnological production of terpenes, ketocarotenoids or vitamin B6, among other products of interest.
- the present invention provides a chemo-enzymatic process useful for the preparation of 1-deoxy-D-xylulose based on the use of the enzyme D-fructose-6-phosphate aldolase (FSA).
- FSA D-fructose-6-phosphate aldolase
- a first aspect of the present invention relates to a process for obtaining 1-deoxy-D-xylulose (scheme 1), which comprises the following steps: a) the aldolic addition of benzyloxyacetaldehyde to hydroxyacetone catalyzed by FSA to obtain 5- O-benzyl-1-deoxy-D-xylulose; and b) removal of the benzyl group from the adduct, 5-O-benzyl-1-deoxy-D-xylulose, by catalytic hydrogenolysis to give rise to 1-deoxy-D-xylulose.
- the catalytic hydrogenolysis of step (b) of the process of the invention consists in the addition of H 2 in the presence of a catalyst, preferably a metal catalyst.
- a catalyst preferably a metal catalyst.
- Metallic catalyst refers in this invention to a catalyst whose function in hydrogenation processes is known to a person skilled in the art.
- this metal catalyst can be selected from the group comprising Pd, Ni, Pt, Ru or Rh. More preferably the metal catalyst is Pd / C.
- the process of the invention has advantages with respect to the chemo-enzymatic synthesis existing in the state of the art, having a lower number of stages, higher overall yields and a very high stereochemistry. For example:
- the FSA uses HA in the aldol addition reaction in place of the DHAP thio analogue, eliminating a total of 4 synthetic stages (not counting the preparation of the DHAP thio-analogue and the benzyloxyacetaldehyde) compared to the methodology with DHAP-dependent aldolases, mentioned In the background.
- the hydrolysis step of the thiophosphate group is eliminated.
- the FSA is stable at a minimum of 4 0 C for seven months without loss of activity, and also does not use or generate toxic waste, as is the case, for example, in the case of using DHAP-aldolases, when using dihydroxyacetone ( DHA) in the presence of arsenic salts, a highly toxic product and, therefore, dangerous for health and the environment.
- DHA dihydroxyacetone
- -FSA has the ability to control the stereochemistry of the aldol addition and, therefore, the configuration of the new stereogenic centers created depends on the enzyme and not on the reagents of the aldol addition.
- the enzyme D-fructose-6-phosphate aldolase corresponds to the E. coli FSA of SEQ ID NO: 1.
- the FSA used has been cloned into the E. coli strain MC4100, derived from the E. coli strain K-12 (Schürmann, M .; Sprenger, GAJ Biol. Chem. (2001) 276 11055; Casadaban, MJ (1976) J. Mol. Biol. 104, 541-555) and subsequently purified.
- Said FSA consists of the wild form of enzyme D-fructose-6-phosphate aldolase that is naturally expressed in E.
- FSA wild D-fructose-6-phosphate aldolase
- an analogous amino acid sequence is intended to include any amino acid sequence that can be isolated from a microorganism or by directed mutagenesis and that possesses the aldolic addition capacity between DHA and an acceptor benzyloxyacetaldehyde.
- an analogous amino acid sequence is substantially homologous to the amino acid sequence discussed above.
- the expression “substantially homologous” means that the amino acid sequences in question have a degree of identity of at least 30%, preferably of at least 75%, more preferably of, at least 85%, or even more preferably, at least 95%.
- HA (0.68 g, 9.2 mmol) and FSA aldolase powder (0.113 g, 47 U) were dissolved in 50 mM boric acid / borate buffer pH 7.0 (80 ml_). To this mixture was added benzyloxyacetaldehyde (1.16 g, 7.7 mmol) dissolved in DMF (20 ml_). The reaction mixture was placed on an orbital shaker (120 rpm) at 25 ° C. After 24 hours the conversion reached 99%.
- Step 2 Deprotection of the benzyl group of 5-O-benzyl-1-deoxy-D-xylulose, by hydrogenolysis with H 2 in the presence of palladium. Obtaining 1-deoxy-D-xylulose.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
L'invention concerne un procédé d'obtention de 1-déoxy-D-xylulose qui comprend l'addition aldolique de benzyloxyacétaldéhyde à de l'hydroxyacétone catalysée par FSA pour obtenir de la 5-O-benzyl-1-déoxy- D-xylulose; et l'élimination ultérieure du groupe benzyle de l'adduit, la 5-O-benzyl-1-déoxy- D-xylulose, par hydrogénolyse catalytique pour produire de la 1-déoxy- D-xylulose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200900254A ES2343448B1 (es) | 2009-01-29 | 2009-01-29 | Procedimiento quimo-enzimatico para la sintesis de 1-deoxi-d-xilulosa. |
ESP200900254 | 2009-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010086482A1 true WO2010086482A1 (fr) | 2010-08-05 |
Family
ID=42334966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2010/070043 WO2010086482A1 (fr) | 2009-01-29 | 2010-01-26 | Procédé chimio-enzymatique pour la synthèse de 1-déoxy-d-xylulose |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2343448B1 (fr) |
WO (1) | WO2010086482A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109207139A (zh) * | 2018-10-19 | 2019-01-15 | 河南国中铭泰化工科技有限公司 | 一种非交联植物胶压裂液及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326176B1 (en) * | 1997-12-18 | 2001-12-04 | The Scripps Research Institute | Aldol condensations by catalytic antibodies |
WO2008067997A1 (fr) * | 2006-12-05 | 2008-06-12 | Isobionics B.V. | Préparation de 4-hydroxy-2,5-diméthyl-2,3-dihydrofuran-3-one |
-
2009
- 2009-01-29 ES ES200900254A patent/ES2343448B1/es not_active Expired - Fee Related
-
2010
- 2010-01-26 WO PCT/ES2010/070043 patent/WO2010086482A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326176B1 (en) * | 1997-12-18 | 2001-12-04 | The Scripps Research Institute | Aldol condensations by catalytic antibodies |
WO2008067997A1 (fr) * | 2006-12-05 | 2008-06-12 | Isobionics B.V. | Préparation de 4-hydroxy-2,5-diméthyl-2,3-dihydrofuran-3-one |
Non-Patent Citations (5)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109207139A (zh) * | 2018-10-19 | 2019-01-15 | 河南国中铭泰化工科技有限公司 | 一种非交联植物胶压裂液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
ES2343448A1 (es) | 2010-07-30 |
ES2343448B1 (es) | 2011-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101151368B (zh) | 基因表达盒及转化体、及使用该转化体的2-脱氧-青蟹肌糖的制备方法及2-脱氧-青蟹肌糖的精制方法 | |
US10253335B2 (en) | Method for producing beta-santalene | |
ES2616085T3 (es) | Valenceno sintasa | |
ES2891377T3 (es) | Polipéptidos de valenceno sintasa, moléculas de ácido nucleico codificantes y usos de los mismos | |
CN1038836A (zh) | 新氨基转移酶、它的生产及应用 | |
Sagami et al. | Purification and properties of geranylgeranyl-diphosphate synthase from bovine brain. | |
CN107118976A (zh) | 阴沟肠杆菌及其应用 | |
CN105647997A (zh) | 肌肉肌醇和肌肉肌醇衍生物的制造方法 | |
Siebertz et al. | Labelling in vivo and in vitro of molecular species of lipids from chloroplast envelopes and thylakoids | |
CN105802935B (zh) | 一种酯酶phe14及其编码基因和应用 | |
CN107460203A (zh) | 一种产红景天苷及其类似物的重组菌及构建方法及用途 | |
CN106133143A (zh) | 用于生产3‑羟基丙酸的酯的方法 | |
ES2343448B1 (es) | Procedimiento quimo-enzimatico para la sintesis de 1-deoxi-d-xilulosa. | |
CN107460220A (zh) | 一种红景天苷及其类似物的制备方法 | |
CN107326061B (zh) | 一种采用生物酶催化立体选择性拆分卡洛芬对映体的方法 | |
CN109321487A (zh) | 假单胞菌zjut126及在生产L-草铵膦中的应用 | |
JP4858676B2 (ja) | L−スレオ−3,4−ジヒドロキシフェニルセリンの製造法 | |
Kobes et al. | Variant properties of bovine liver 2-keto-4-hydroxyglutarate aldolase; its β-decarboxylase activity, lack of substrate stereospecificity, and structural requirements for binding substrate analogs | |
JP4405631B2 (ja) | 共役リノール酸異性体の精製方法 | |
CN108265095B (zh) | 一种15n稳定性同位素标记5-甲基脱氧胞苷的制备方法 | |
CN106085985B (zh) | 一种酯酶WDEst9及其编码基因和应用 | |
CN104313069B (zh) | β‑井冈霉烯胺的生物制备方法 | |
JP3747640B2 (ja) | 光学活性1,2−ジオール環状炭酸エステルの製造法 | |
CN107142227A (zh) | 产酸克雷伯菌及其应用 | |
US20220315967A1 (en) | Methods for producing d-tryptophan and substituted d-tryptophans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10735495 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10735495 Country of ref document: EP Kind code of ref document: A1 |